Adicet Bio, Inc. Shares Outstanding (Cover Page)
Adicet Bio, Inc. (ACET) had Shares Outstanding (Cover Page) of 9.36 million shares as of 2026-08-03, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-05
- 2026-08-03: Entity Common Stock, Shares Outstanding 9.36M shares.
- 2026-05-19: Entity Common Stock, Shares Outstanding 9.35M shares.
- 2026-05-11: Entity Common Stock, Shares Outstanding 9.35M shares.
- 2026-03-10: Entity Common Stock, Shares Outstanding 9.60M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-03 | 9.36M shares 10-Q · filed 2026-08-05 |
| 2026-05-19 | 9.35M shares 10-K/A · filed 2026-05-20 |
| 2026-05-11 | 9.35M shares 10-Q · filed 2026-05-13 |
| 2026-03-10 | 9.60M shares 10-K · filed 2026-03-12 |
| 2025-11-03 | 153.26M shares 10-Q · filed 2025-11-05 |
| 2025-08-05 | 83.25M shares 10-Q · filed 2025-08-07 |
| 2025-05-02 | 82.71M shares 10-Q · filed 2025-05-06 |
| 2025-03-03 | 82.69M shares 10-K · filed 2025-03-06 |
| 2024-11-04 | 82.40M shares 10-Q · filed 2024-11-06 |
| 2024-08-09 | 82.40M shares 10-Q · filed 2024-08-13 |
| 2024-05-10 | 82.17M shares 10-Q · filed 2024-05-14 |
| 2024-03-14 | 82.15M shares 10-K · filed 2024-03-19 |
| 2023-11-06 | 43.16M shares 10-Q · filed 2023-11-08 |
| 2023-08-07 | 43.07M shares 10-Q · filed 2023-08-09 |
| 2023-05-05 | 42.96M shares 10-Q · filed 2023-05-09 |
| 2023-03-10 | 42.95M shares 10-K · filed 2023-03-15 |
| 2022-11-04 | 42.85M shares 10-Q · filed 2022-11-08 |
| 2022-08-05 | 40.03M shares 10-Q · filed 2022-08-10 |
| 2022-05-09 | 40.00M shares 10-Q · filed 2022-05-12 |
| 2022-03-10 | 39.88M shares 10-K · filed 2022-03-15 |
| 2021-11-09 | 31.96M shares 10-Q · filed 2021-11-10 |
| 2021-08-10 | 31.84M shares 10-Q · filed 2021-08-12 |
| 2021-05-12 | 31.81M shares 10-Q · filed 2021-05-17 |
| 2021-03-10 | 31.78M shares 10-K/A · filed 2021-08-16 |
| 2020-11-03 | 19.60M shares 10-Q · filed 2020-11-05 |
| 2020-07-29 | 36.45M shares 10-Q · filed 2020-07-30 |
| 2020-05-06 | 36.45M shares 10-Q · filed 2020-05-07 |
| 2020-03-11 | 36.45M shares 10-K · filed 2020-03-12 |
| 2019-11-01 | 36.44M shares 10-Q · filed 2019-11-05 |
| 2019-08-13 | 36.22M shares 10-Q · filed 2019-08-14 |
| 2019-05-14 | 35.74M shares 10-Q · filed 2019-05-15 |
| 2019-03-15 | 28.06M shares 10-K · filed 2019-03-18 |
| 2018-11-12 | 28.06M shares 10-Q · filed 2018-11-13 |
| 2018-08-08 | 28.05M shares 10-Q · filed 2018-08-09 |
| 2018-05-09 | 28.05M shares 10-Q · filed 2018-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |